The new modified prolate IOL (Tecnis Z9000, Pfizer) may have ushered in a new era in the design of IOLs, suggested speakers at a recent symposium on advances in cataract surgery. The aspherical design used in the Tecnis lens could become the standard within a few years, and, along with new viscoelastic or viscoadaptive devices, should enable surgeons to achieve better results from cataract surgery.
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.